# Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

> **NCT00244192** · PHASE2 · COMPLETED · sponsor: **Center for Integrated Rehabilitation and Organ Failure Horn** · enrollment: 16 (—)

## Conditions studied

- COPD
- Cachexia

## Interventions

- **DRUG:** infliximab (Remicade)

## Key facts

- **NCT ID:** NCT00244192
- **Lead sponsor:** Center for Integrated Rehabilitation and Organ Failure Horn
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 16 (—)
- **Last updated:** 2005-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244192, "Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00244192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*